Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultiva and Xylocaine in Feticide Procedures
NCT02597699Phase 3Completed
- Sponsor
- CHU Montpellier
- Start
- Dec 2015
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of remifentanil in termination of pregnancy, sponsored by CHU Montpellier. Started Dec 2015; status: completed.
02
Drugs
remifentanil
03
Conditions
termination of pregnancy
Beyond the preview
Go deeper on NCT02597699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02597699.